Overview and symptom overlap
Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) are neurodevelopmental conditions arising in childhood and affecting cognition, behaviour, social interaction and emotional regulation. ASD is characterised by social communication difficulties, restricted or repetitive behaviours and atypical sensory responses. ADHD involves inattention, hyperactivity and impulsivity, often presenting as distractibility, disorganisation, restlessness and reduced behavioural inhibition. Both conditions commonly affect executive functioning, including planning, working memory and emotional control.
Traumatic brain injury (TBI), although acquired rather than developmental, can affect the same domains, producing impaired attention, reduced processing speed, memory difficulty, impulsivity, emotional dysregulation, fatigue and social communication problems.
The result is substantial clinical overlap. TBI may produce ADHD-like symptoms, sometimes described as “secondary ADHD”, and may also resemble ASD through social difficulty, behavioural rigidity or sensory sensitivity. The central distinction is usually timing: ASD and ADHD follow a developmental course, whereas TBI symptoms arise after an identifiable injury and represent a change from baseline.
Causation and diagnostic complexity
The relationship between TBI and neurodevelopmental conditions is bidirectional. ADHD may increase the risk of a TBI because of impulsivity and risk-taking behaviours, while TBI can cause new ADHD-type symptoms. The relationship with ASD is less clear, but TBI may unmask pre-existing autistic traits, mimic ASD features or disrupt development, particularly in children.
The question is: does the current presentation reflect a pre-existing condition, the consequences of TBI, or an interaction between the two?
Assessment should consider change from baseline, supported by contemporaneous and collateral evidence. A robust assessment will usually include developmental history, school and employment records, family evidence, prior diagnoses, neuropsychological testing and TBI-specific evidence such as injury severity, imaging where available and recovery trajectory. No single test is determinative; a multi-source, longitudinal approach is required.
Impact of TBI where ASD/ADHD pre-exist
In claimants with pre-existing ASD / ADHD, TBI can both amplify existing difficulties and introduce new impairments. The combined effect is often greater cognitive fatigue, reduced tolerance of sensory and environmental demands, impaired executive functioning and poorer emotional regulation.
In adults, this may affect employment, independent living, family functioning and ability to sustain daily routines. In those with ASD, noise, light or other sensory triggers may become easier to provoke, more intense and slower to recover from after TBI.
In children, the impact may be particularly significant because the injury occurs against a background of ongoing development. TBI may worsen attention, impulsivity, behaviour, emotional regulation, learning and social interaction. Additional educational support is often required, particularly where fatigue and slowed information processing reduce the child’s ability to manage normal school demands.
In respect of educational support, whilst the detail of implementation remains to be seen, the 2026 SEND reform proposals may have important implications for child TBI claims involving ASD and/or ADHD. Under the current proposals, EHCPs will only remain for those children with the most complex needs, with a greater focus on mainstream provision, earlier intervention and Individual Support Plans (ISPs) for children with identified SEND.
In practice, this may lead to greater emphasis on establishing the precise functional consequences of the injury, the extent to which those needs can be met through statutory provision, and whether additional privately funded support is reasonable and necessary. It should not be assumed that an EHCP will be available in every case, nor that an ISP will necessarily provide support of equivalent scope or intensity. It will be crucial to identify what is available to the child, whether it is sufficient in practice, whether any shortfall is causally related to the TBI, and whether proposed privately funded intervention is reasonable, evidenced and proportionate.
For practitioners, this reinforces the importance of obtaining detailed educational records, evidence of pre‑injury functioning, and expert opinion addressing not only diagnosis and causation, but also the nature and extent of any ongoing educational and therapeutic needs.
Treatment and management
Management should address both neurodevelopmental and acquired factors through a coordinated multidisciplinary approach.
- Medical treatment: medication may assist attention, executive dysfunction, mood or emotional regulation where clinically appropriate.
- Cognitive rehabilitation: interventions may target attention, memory, processing speed and executive skills.
- Psychological and behavioural support: strategies for emotional regulation, impulse control and adjustment, with psychoeducation for families.
- Environmental adaptations: structured routines, predictable settings and reduced sensory or cognitive load.
- Specialist therapies: speech and language therapy (SALT) for communication issues and occupational therapy for functional independence and daily living skills
- Family, educational and workplace support: these are often central to improving functional recovery and reducing misunderstanding of overlapping symptoms.
Life expectancy
Recent UK studies have reported reduced life expectancy amongst adults with diagnosed ASD and ADHD. A 2023/2024 study published in The Lancet Regional Health (Europe) reported reduced life expectancy in diagnosed autistic adults, whilst a 2025 UK study published in The British Journal of Psychiatry reported an apparent reduction in life expectancy amongst adults with diagnosed ADHD. Whilst these findings raise potentially important questions in the medico-legal sphere, there is likely to be debate as to how far such findings can properly be applied in individual cases, particularly given the potential influence of co-existing medical conditions, psychiatric morbidity, lifestyle factors and inequalities in access to healthcare. Nevertheless, this research has potential significance in TBI claims where future losses generally extend over many decades. It is important to consider at an early stage whether life expectancy is likely to become a relevant issue and whether specialist medical and/or statistical evidence may be required before seeking to depart from the standard mortality assumptions underpinning the Ogden Tables.
Practical medico-legal considerations
In practice, the following points are important:
- Establish pre-injury baseline early using collateral evidence.
- Avoid assuming all symptoms are due either to TBI, or to a pre-existing condition.
- Focus on timing, trajectory and functional change.
- Consider symptoms over time.
- Obtain input from neurology, psychiatry, psychology and rehabilitation specialists.
- Consider life expectancy evidence carefully: identify whether there is a TBI-related basis for reduction and whether the opinion is clinical, statistical or both.
- In child cases, obtain school and SEND evidence early, including pre-injury support, current provision, EHCP/ISP status, attendance, fatigue and therapy needs.
Conclusion
The overlap between ASD, ADHD and TBI can obscure diagnosis and complicate attribution, particularly in medico-legal cases. The key issue is not simply whether symptoms are present, but when they arose, how they have changed, and whether they represent a departure from pre-injury functioning. Neurodevelopmental conditions may increase vulnerability to injury, while TBI may mimic, worsen or interact with those conditions. Accurate diagnosis and fair attribution depend on careful history-taking, collateral evidence, temporal analysis and multidisciplinary assessment. Effective management requires integrated medical, rehabilitative, psychological and environmental support. As the medico-legal landscape evolves, it is important to consider to wider issues affecting this cohort of individuals, including changes to SEND provision (in respect of child claimants) and emerging research concerning life expectancy, both of which may have important implications for the assessment of future needs and losses.
If you would like to know more about this area or have a claim with similar issues, please do not hesitate to reach out to our Traumatic Brain Injury team.
Authors: Jamie Azim, Retu Joshi, Rebecca Byrne and Nicole Stepanova
